Clinical trial
Analysis of Diabetic Retinopathy, Glaucoma and Macular Degeneration Diagnosis Via Digital Fundus Images With Artificial Intelligence
NCT06645964 is registered in ClinicalTrials.gov with Retinow Health Technologies and R&D Industry Joint Stock Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analysis of Diabetic Retinopathy, Glaucoma and Macular Degeneration Diagnosis Via Digital Fundus Images With Artificial Intelligence
- Lead sponsor
- Retinow Health Technologies and R&D Industry Joint Stock Company
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 1, 2023
- Completion date
- October 1, 2023
- Enrollment
- 915 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.